▶ 調査レポート

世界の飼料用抗生物質市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Global Feed Antibiotics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の飼料用抗生物質市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Global Feed Antibiotics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2202A143資料のイメージです。• レポートコード:MRC2202A143
• 出版社/出版日:Mordor Intelligence / 2022年1月28日
• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:農業
• 販売価格(消費税別)
  Single User¥631,750 (USD4,750)▷ お問い合わせ
  Team User¥864,500 (USD6,500)▷ お問い合わせ
  Corporate License¥1,163,750 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、世界の飼料用抗生物質市場規模が、年平均3.6%成長すると予測しています。本調査レポートでは、飼料用抗生物質の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(テトラサイクリン、ペニシリン、スルホンアミド、マクロライド、アミノグリコシド)分析、動物種類別(反芻動物、家禽、豚、養殖、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ)分析、競争状況、市場機会・将来傾向、新型コロナウイルス感染症による市場への影響などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の飼料用抗生物質市場規模:種類別(テトラサイクリン、ペニシリン、スルホンアミド、マクロライド、アミノグリコシド)
・世界の飼料用抗生物質市場規模:動物種類別(反芻動物、家禽、豚、養殖、その他)
・世界の飼料用抗生物質市場規模:地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ)
・競争状況(Bayer HealthCare AG、Merck Animal Health、Zomedica、Elanco、Sanofi-Aventis SA、LG Life Sciences Limited、American Regent Inc.、ECO Animal Health、Zoetis、Alpha-Vet Animal Health)
・市場機会・将来傾向
・新型コロナウイルス感染症による市場への影響

The global feed antibiotics market is projected to register a CAGR of 3.6% during the forecast period. Asia-Pacific is projected to be the fastest-growing market. Industrialization, increasing animal disease, expansion of the meat market, and changing demographics are the major driving the market. The feed antibiotics are used in the livestock industry to obtain high feed efficiency rate and to prevent and treat disease in the herds of animals or in an individual animal. Tetracyclines, Penicillins, sulfonamide, macrolides are some of the major antibiotics used in the livestock industry. The feed antibiotics, apart from being used for their anti microbial properties are being used as growth promoting agent and performance enhancer.As an impact of COVID-19, the global consumption of meat and other animal products are in the verge of a declining phase as consumer preference for plant based foods are rapidly rising. In addition, animal products without any traces of synthetic compounds are anticipated to grow in the forecast period. Hence the preference for animal feed with chemical ingredients including antibiotics are projected to decline during the forecast period.

Key Market Trends

Increasing Meat Consumption

Despite the increasing global concern regarding the antimicrobial resistance in humans due to the use of antibiotics in livestock, meat consumption is increasing every year. According to the Organisation for Economic Co-ordination and Development, meat consumption has raised from 114 million metric ton in 2017 to 116 million metric ton in 2018. Poultry meat is the most consumed by humans with per capita consumption of 30.6 kilograms per year, followed by pork with per capita consumption of 23.5 kilograms per year and beef and veal with per capita consumption of 14.8 kilograms per year. In general, antibiotics in livestock is used to treat and prevent disease in the livestock. But in a few countries, farmers also use this to gain weight of their animals. According to the American meat institute, consuming the meat of the animal treated with antibiotic cause antimicrobial resistance in humans (resistance to that antibiotics). Government of various countries is following strict regulations to monitor and regulate the usage of antibiotics by educating farmers and so on. This abolishes the misconception of usage in livestock leading to an increase in meat consumption, increasing the need for quality meat production with the help of antibiotics.

Asia Pacific is the Largest Market

China has the largest market revenue share in Asia Pacific and is forecasted to grow further in the forecast period. This keeps Asia-Pacific as the biggest market for antibiotics, by holding the largest market share in terms of revenue with the highest growth rate, followed by Europe, and North-America holds the second and third position respectively. The United States is occupying the second position after China. According to, The Centre for Disease Dynamic, Economics and Policy, Brazil, India, China, Russia, and South Africa will experience more growth in antibiotic consumption due to the rapid increase in their population which also increases the need for animal protein driving the feed antibiotic market.

Competitive Landscape

The feed antibiotics market is a consolidated market with few major players like Bayer Health care, Merck Animal Health, Boehringer Ingelheim International GmbH, and Elanco accounting for majority of the total market share. The companies follow mergers and acquisitions, expansions, investment in R&D are some of the few most adopted strategies by these players in expanding their business. For instance, in February 2019, Merck Animal Health has expanded the capacity of its facility in Millsboro, Delaware.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Type
5.1.1 Tetracyclines
5.1.2 Penicillins
5.1.3 Sulfonamides
5.1.4 Macrolides
5.1.5 Aminoglycosides
5.1.6 Cephalosporins
5.1.7 Others
5.2 Animal Type
5.2.1 Ruminant
5.2.2 Poultry
5.2.3 Swine
5.2.4 Aquaculture
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 Spain
5.3.2.2 United Kingdom
5.3.2.3 Germany
5.3.2.4 France
5.3.2.5 Russia
5.3.2.6 Italy
5.3.2.7 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 India
5.3.3.3 Japan
5.3.3.4 Thailand
5.3.3.5 Australia
5.3.3.6 Rest of Asia Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 South Africa
5.3.5.2 Egypt
5.3.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE
6.1 Most adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 Bayer HealthCare AG
6.3.2 Merck Animal Health
6.3.3 Zomedica
6.3.4 Elanco
6.3.5 Sanofi-Aventis SA
6.3.6 LG Life Sciences Limited
6.3.7 American Regent Inc.
6.3.8 ECO Animal Health
6.3.9 Zoetis
6.3.10 Alpha-Vet Animal Health

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET